Outcomes Analysis of the Role of Plastic Surgery in Extremity Sarcoma Treatment

Abstract

Over the past 5 years we have developed a multidisciplinary service for the treatment of extremity sarcoma. This service includes orthopedic oncology, neurosurgery, medical and radiation oncology, and plastic surgery. Prior to 2007, the role of plastic surgery in this multidisciplinary team was limited. After 2007, plastic surgery at our institution played an increasingly integral role in multidisciplinary care. Based on the development of the plastic surgery service at our institution, we were able to evaluate the role of plastic surgery in the outcomes following extremity reconstruction after sarcoma resection. We hypothesize that plastic surgery involvement would reduce the amputation rate without altering recurrence rates. We found a decrease in lower-extremity amputation of approximately 20% without any significant change in recurrence rates. The incidence of infectious complications requiring IV antibiotics decreased by about 20%. The incidence of skin graft loss decreased by 75%. We do report a significant increase in partial flap necrosis. Overall, plastic surgery is an essential component of the multidisciplinary team in the care of extremity sarcoma.

Keywords

sarcoma - oncology - plastic surgery - extremity

• References

• 1 American Cancer Society. What are the key statistics for sarcoma? Cancer Reference Information; Detailed Guide. Available at: www.cancer.org . Accessed September 8, 2009
• 2 Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-1689
• 3 Brennan MF. The surgeon as a leader in cancer care: lessons learned from the study of soft tissue sarcoma. J Am Coll Surg 1996; 182: 520-529
• 4 Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg 1975; 182: 597-602
• 5 Stojadinovic A, Jaques DP, Leung DH, Healey JH, Brennan MF. Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann Surg Oncol 2001; 8: 509-518
• 6 Pisters PW. Combined modality treatment of extremity soft tissue sarcomas. Ann Surg Oncol 1998; 5: 464-472
• 7 Brennan MF. The Society of Surgical Oncology. The enigma of local recurrence. Ann Surg Oncol 1997; 4: 1-12
• 8 Lewis JJ, Leung D, Casper ES, Woodruff J, Hajdu SI, Brennan MF. Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. Arch Surg 1999; 134: 190-194
• 9 Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS. Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study. Arch Phys Med Rehabil 1999; 80: 615-618
• 10 Niimi R, Matsumine A, Kusuzaki K , et al. Usefulness of limb salvage surgery for bone and soft tissue sarcomas of the distal lower leg. J Cancer Res Clin Oncol 2008; 134: 1087-1095
• 11 Aksnes LH, Bauer HC, Jebsen NL , et al. Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br 2008; 90: 786-794
• 12 Zahlten-Hinguranage A, Bernd L, Sabo D. [Amputation or limb salvage? Assessing quality of life after tumor operations of the lower extremity]. Orthopade 2003; 32: 1020-1027
• 13 Ramanathan RC, A'Hern R, Fisher C, Thomas JM. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol 2001; 8: 278-289
• 14 Gerrand CH, Wunder JS, Kandel RA , et al. The influence of anatomic location on functional outcome in lower-extremity soft-tissue sarcoma. Ann Surg Oncol 2004; 11: 476-482